Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases.
BACKGROUND: Anti-angiogenic therapy with bevacizumab (an anti-vascular endothelial growth factor (VEGF) antibody) predominantly targets immature blood vessels. Bevacizumab has shown a survival benefit in non-small cell lung carcinoma (NSCLC) and has recently been demonstrated to be safe in patients...
Main Authors: | Jubb, A, Cesario, A, Ferguson, M, Congedo, M, Gatter, K, Lococo, F, Mulè, A, Pezzella, F |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
2011
|
Lignende værker
-
Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases
af: Jubb, A, et al.
Udgivet: (2011) -
Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas.
af: Passalidou, E, et al.
Udgivet: (2002) -
Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas.
af: Passalidou, E, et al.
Udgivet: (2002) -
Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases.
af: Liu, D, et al.
Udgivet: (2010) -
Vascular endothelial growth factor expression in lung cancer.
af: O'Byrne, K, et al.
Udgivet: (1998)